So far, the model is formulated mostly based on validated knowledge in ECs, however, experimental evidence suggests that HIF-let-7-AGO-VEGF pathway is present in other cell/tissue types, including muscle and tumor, and it plays a fundamental role in the angiogenic adaptations of these cells in response to hypoxia [21]. The gene discussed is VEGFA; the disease is neoplasm.